BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paradigms Foundation
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260129T200000
DTEND;TZID=Europe/Paris:20260129T210000
DTSTAMP:20260120T094718Z
CREATED:20251119T105946Z
LAST-MODIFIED:20260120T094718Z
UID:12496-1769716800-1769720400@paradigms.foundation
SUMMARY:Live Webinar on the Clinical management of NMOSD in Belgium
DESCRIPTION:Neuromyelitis optica spectrum disorder (NMOSD) is a rare but highly disabling autoimmune disease that predominantly affects the optic nerves and spinal cord. Delayed or missed diagnosis can have life-changing consequences\, but evolving diagnostic criteria and new targeted therapies are reshaping outcomes for people living with NMOSD. \n\n\n\nIn this webinar\, Professor Vincent van Pesch will discuss practical\, real-world approaches to diagnosing and managing NMOSD in Belgium\, from the first suspicious attack to long-term treatment decisions and patient follow-up. The webinar will be introduced and moderated by Doctor  Melissa Cambron. \n\n\n\nRISIV/INAMI Accreditation: The number 26002105 has been assigned to this activity.  \n\n\n\nActivity status: Application submitted – Verification by the NHIF. \n\n\n\nKey Highlights\n\n\n\n\nA clear overview of how NMOSD is recognised and differentiated from other neurological conditions such as MS.\n\n\n\nAn introduction to how clinicians typically confirm the diagnosis in everyday practice.\n\n\n\nGeneral principles for managing acute attacks and supporting long-term care.\n\n\n\nHow patient needs\, treatment access\, and care pathways influence clinical decision-making in Belgium.\n\n\n\nPractical considerations for improving patient experience and long-term outcomes.\n\n\n\nLive Q&A to address your clinical questions\n\n\n\n\nRegister to access the webinar\n\n\n\nThis session will be held live on Zoom. We warmly encourage you to register in advance to secure your place and take part in the exchange of knowledge and discussions. \n\n\n\n\nRegister here to join the live webinar\n\n\n\n\nLanguage\n\n\n\nThe session will be held in English with translated auto-captions into many languages\, offered by Zoom platform.  \n\n\n\nThis webinar might interest you if you are: \n\n\n\n\nNeurologists with a particular interest in multiple sclerosis therapies and treatments\n\n\n\nNeurologists in training\n\n\n\nNurses engaged in the care of patients with multiple sclerosis\n\n\n\nPatient representatives\n\n\n\n\nQuestions and discussion\n\n\n\nIf there are specific questions you would like to see addressed during the session\, we encourage you to share them in advance at learning@paradigms.foundation. This will allow the speakers to incorporate them into their presentations. \n\n\n\nYou will also have the opportunity to raise questions directly and actively contribute to the discussion during the webinar and the dedicated Q&A session. \n\n\n\nTechnology used\n\n\n\nThe session will be conducted via Zoom\, with access credentials shared upon completion of your registration. \n\n\n\nTime and date\n\n\n\nThe session will be held in English on Thursday\, 29th January 2026 from 20:00 to 21:00 CET. \n\n\n\nInvited Speaker\n\n\n\n\n\n\n\nProfessor Vincent van Pesch\n\n\n\nProfessor of Neurology and Associate Head of the Neurology department of the Cliniques Universitaires Saint-Luc \n\n\n\nDr Van Pesch obtained his medical degree in 1999 from Université Catholique de Louvain and then completed his PhD thesis in neuroimmunology in 2003. He served as neurology resident at Department of Neurology\, Saint-Luc Hospital and then progressed in positions from Adjunct Clinical Head to Associate Clinical Head and finally to Adjunct Chief of Neurology Department at Cliniques Universitaires Saint-Luc. He is also responsible for a number of other services within the same place such as coordination and supervision of the neurophysiology unit and supervision and teaching of electroencephalography and evoked potentials to neurology residents. \n\n\n\nAt Université Catholique de Louvain\, Dr Van Pesch is a Profssor of Neurology and is responsible for teaching neuroimmunology and cerebrospinal fluid/neurochemistry analysis as he is the Principal investigator at Neurochemistry Unit at UCL. \n\n\n\nDr Van Pesch also greatly contributes to scientific publications and has over 200 published papers in a number of renowned journals. He is also co-editor of Frontiers Neurology\, section of Multiple Sclerosis and neuroimmunology and section of Neuroepidemiology and also Co-editor of the Acta Neurologica Belgica. \n\n\n\n\n\n\n\nProfessor Melissa Cambron\n\n\n\nMD\, PhD\, neuroinflammatory specialist at AZ Sint-Jan Bruges \n\n\n\nMelissa Cambron\, MD\, PhD\, is a neuroinflammatory specialist at AZ Sint-Jan Bruges\, a position she has held since 2018\, and is affiliated with Ghent University. She completed her specialization and obtained her PhD at the Vrije Universiteit Brussel (VUB). Dr. Cambron further expanded her clinical and academic expertise through a one-year fellowship in neurology at CHRU Lille under the supervision of Professor Patrick Vermersch. Her clinical and research interests focus on neuroinflammatory and neuroimmunological disorders\, including neuromyelitis optica spectrum disorders. \n\n\n\nRegistration\n\n\n\nRegistration is required and can be finalized either via the button located at the top of this page or through the following button below. \n\n\n\n\nRegistration\n\n\n\n\nFunding\n\n\n\nThis webinar is organized with the financial support of Alexion. Alexion has not been involved in the elaboration of the presentations.
URL:https://paradigms.foundation/event/live-webinar-on-the-clinical-management-of-nmosd-in-belgium/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2025/11/LAU-PROD-banner-live-webinar-sessions-260129-1080x655px-02-1.jpg
END:VEVENT
END:VCALENDAR